リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「High Serum Uric Acid Is Highly Associated with a Reduced Left Ventricular Ejection Fraction Rather than Increased Plasma B-type Natriuretic Peptide in Patients with Cardiovascular Diseases」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

High Serum Uric Acid Is Highly Associated with a Reduced Left Ventricular Ejection Fraction Rather than Increased Plasma B-type Natriuretic Peptide in Patients with Cardiovascular Diseases

大木, 理次 東京慈恵会医科大学 DOI:info:doi/10.1038/s41598-018-37053-0

2021.08.11

概要

High serum uric acid (UA) has been reported to be associated with left ventricular (LV) dysfunction; however, the relationship between UA and plasma B-type natriuretic peptide (BNP), a sensitive biomarker of heart failure, is still unclear. This study investigated their relationship to provide an accurate assessment of high UA. The study patients consisted of 3,077 subjects who underwent cardiac catheterization because of various cardiovascular disorders. Since the explanatory factors of multiple regression analysis were mostly confounding with each other, subgroup analysis was performed by quartering the study population using the respective risk factors and by covariance structure analysis.
This analysis revealed that UA was almost always well associated with a reduced LV ejection fraction (LVEF), but generally not with BNP. UA was significantly associated with BNP in lean aged females, but not in obese adolescent males, although LVEF was significantly reduced in response to a high UA in both groups. A high UA is a direct risk factor for cardiac dysfunction from the perspective of BNP; however, augmentation of BNP in response to a high UA would likely be restricted among obese adolescent males. On the other hand, the observed LV systolic dysfunction, such as LVEF, reflects a high UA on an almost constant basis.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1. Kang, I). H. et al. A role for uric acid in the progression of renal disease. J. Am. Soc. Nephrol.13, 2888-2897, https://doi. org/10.1097/01.ASN.0000034910.58454.FD (2002).

2. Uchida, S. et al. Targeling Uric Acid and the Inhibition of Progression to End-Stage Renal Disease-Λ Propensity Score Analysis. PLoS One 10, eO 145506, https://doi.org/10.1371/journal.pone.0145506 (2015).

3. Feig D. 1., Kang D. H., Johnson R. J. Uric acid and cardiovascular risk. N. Engl. J. Med. 359, 1811-1821, https://doi.org/10.1056/NI-JMraO800885 (2008), Erratum in: N. Engl. J. Med. 362,2235, https://doi.org/10.1056/NEJMx 100028 (2010).

4. Kuriyama, S. ct al. Serum uric acid and the incidence of CKD and hypertension. Clin. Exp. Nephrol.19,1127-1134, https://doi. org/10.1007/sl0157-015-U20-4(2015).

5. Forman, J. R et al. Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 125,3108-3116, https://doi.Org/10.l161/CIRCULATIONAHA.l 12.096115 (2012).

6. Cicero, A. E et al. Brisighelia Heart Study Group. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects. Eur J Intern Med. 37,38-42, https://doi.org/10.1016/j.ejim.2016.07.026. (2017). Epub20I6 Aug 3.

7. Kodama, S. et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 32,1737-1742, https:// doi.org/10.2337/dc09 0288 (2009).

8. Cicero AFG et al. Brisighelia Heart Study Group. LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighelia Heart Study cohort. Int J Cardiol. 261,204-208, https://doi.org/10.1016/j.ijcard.2018.03.077. Epub 2018 Marl7 (2018).

9. Hare J. M., Johnson R. J. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 2003 107,1951-1953, https://doi.org/10.1161 /01.CIR.0000066420.36123.35 (2003).

10. Sakai, H. et al. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circ. J. 70, 1006-1011,https://doi.org/10. 1253/circj.70.1006 (2006).

11. Volterrani, M., lellamo, E, Sposato, B. & Romeo, E Uric acid lowering therapy in cardiovascular diseases. Int. J. Cardiol. 213,20-22, https://doi.org/10.1 016/j.ijcard.2015.08.088 (2016).

12. Dochner, W. et al. Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications. Int. J. Cardiol. 213, 15-19, https://doi.org/10.1016/j.ijcard.2015.08.089 (2016).

13. Okazaki, I I. et al. Ihe prognostic impact of uric acid in patients with severely decompensated acute heart failure. J. Cardiol. 68, 384-391,https://doi.org/10.1016/j.jjcc.2016.04.013 (2016).

14. Tanaka, Y. et al. Close linkage between scrum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis. Sei. Rep. 7,2519, https://doi.org/1 0.1038/s41598-017-02707-y (2017).

15. Sudoh, T., Kangawa, K., Minamino. N. & Matsuo, Η. Λ new natriuretic peptide in porcine brain. Nature 332, 78-81, https://doi. org/10.1038/332078a0 (1988).

16. Mukoyama, M. et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 87,1402-1412, https://doi.org/10.1172/ JCI115146 (1991).

17. Yasue, H. et al. Localization and mechanism of secretion ofB-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90,195-203, https://doi.0rg/101.1161 /circ.90.1.8025996 (1994).

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る